Cargando…

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy

OBJECTIVE: Metabolites derived from N−3 and N−6 polyunsaturated fatty acids (PUFAs) have both beneficial and detrimental effects on the heart. However, contribution of these lipid mediators to dilated cardiomyopathy (DCM)-associated mitochondrial dysfunction remains unknown. This study aimed to char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosnowski, Deanna K., Jamieson, K. Lockhart, Darwesh, Ahmed M., Zhang, Hao, Keshavarz-Bahaghighat, Hedieh, Valencia, Robert, Viveiros, Anissa, Edin, Matthew L., Zeldin, Darryl C., Oudit, Gavin Y., Seubert, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160304/ https://www.ncbi.nlm.nih.gov/pubmed/35665247 http://dx.doi.org/10.3389/fcvm.2022.879209

Ejemplares similares

Age and Sex Differences in Hearts of Soluble Epoxide Hydrolase Null Mice
por: Jamieson, K. Lockhart, et al.
Publicado: (2020)

Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
por: Samokhvalov, Victor, et al.
Publicado: (2019)

Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids
por: Keshavarz-Bahaghighat, Hedieh, et al.
Publicado: (2020)

Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation
por: Darwesh, Ahmed M., et al.
Publicado: (2019)

Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury
por: Jamieson, K. Lockhart, et al.
Publicado: (2021)

Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility
por: Viveiros, Anissa, et al.
Publicado: (2022)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
por: Darwesh, Ahmed M., et al.
Publicado: (2021)

Genotype‐specific pathogenic effects in human dilated cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

Initial Results of a Prospective Study and Identification of New Strategies to Increase Traceability of Plasma-derived Medicines
por: Najafi, Sheyda, et al.
Publicado: (2018)

A multifactorial aetiology for dilated cardiomyopathy
por: Herrera Flores, Cristian, et al.
Publicado: (2021)

Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications
por: Zhabyeyev, Pavel, et al.
Publicado: (2023)

DILATED CARDIOMYOPATHY WITH CARDIOGENIC SHOCK SECONDARY TO COVID-19 INFECTION
por: RICHARDSON, AUSTIN, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy
por: Kadhi, Ayat, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin
por: Crescente, Marilena, et al.
Publicado: (2020)

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

Inherited human group IVA cytosolic phospholipase A(2) deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation
por: Kirkby, Nicholas S., et al.
Publicado: (2016)

Loss of PI3Kα Mediates Protection From Myocardial Ischemia–Reperfusion Injury Linked to Preserved Mitochondrial Function
por: Zhabyeyev, Pavel, et al.
Publicado: (2023)

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy
por: Zheng, Youyang, et al.
Publicado: (2022)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Early-stage alcohol-induced cardiomyopathy: not so much dilatation and dysfunction
por: Carrillo-Bailen, Magdalena, et al.
Publicado: (2023)

Development and validation of nomogram for unplanned ICU admission in patients with dilated cardiomyopathy
por: Li, Xiao-Lei, et al.
Publicado: (2023)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

β(1)- and α(2c)-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry
por: Woodiwiss, Angela J, et al.
Publicado: (2008)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy
por: Zhang, Lin, et al.
Publicado: (2023)

Giant right atrium in a child with dilated cardiomyopathy: A case report
por: Wang, Benzhen, et al.
Publicado: (2023)

The G-308A polymorphism of the TNF-α gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy
por: Brooksbank, Richard, et al.
Publicado: (2008)

Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023)

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance
por: Mitropoulou, Panagiota, et al.
Publicado: (2020)

Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2022)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
por: Amin, Ravi J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qrr8hoob00qiflg4h6f3logkcb